Merit Medical Systems Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,516	1,357	1,257	1,151	1,075
Revenue Growth (YoY)	11.75%	7.89%	9.24%	7.09%	11.50%
Cost of Revenue	777.64	713.18	673.49	631.88	589.42
Gross Profit	738.27	643.33	583.87	519.1	485.33
Selling, General & Admin	447.01	387.83	366.08	335.33	329.69
Research & Development	97.35	87.47	82.73	75.51	71.25
Operating Expenses	544.37	475.3	448.8	410.84	400.94
Operating Income	193.9	168.04	135.07	108.26	84.4
Interest Expense	-26.46	-31.22	-15.51	-6.34	-5.26
Interest & Investment Income	15.07	26.23	2.46	0.44	0.77
Currency Exchange Gain (Loss)	-0.1	1.96	2	1.42	-1.6
Other Non Operating Income (Expenses)	-2.29	-2.67	-0.8	-0.45	-0.91
EBT Excluding Unusual Items	180.12	162.34	123.21	103.33	77.4
Merger & Restructuring Charges	-8.2	-11.9	-7.6	-7.2	-2.7
Gain (Loss) on Sale of Investments	-	-	-0.27	-0.5	-
Asset Writedown	-	-	-	-1.72	-1.58
Legal Settlements	-	-	-	-	-10.04
Other Unusual Items	-0.98	-0.44	-1.7	-4.61	-9.16
Pretax Income	170.94	149.99	112.09	82.63	53.92
Income Tax Expense	42.45	29.64	17.68	8.11	5.46
Net Income	128.49	120.36	94.41	74.52	48.45
Net Income to Common	128.49	120.36	94.41	74.52	48.45
Net Income Growth	6.76%	27.48%	26.70%	53.79%	-
Shares Outstanding (Basic)	59	58	58	57	56
Shares Outstanding (Diluted)	60	59	58	58	57
Shares Change (YoY)	1.85%	1.73%	1.19%	0.54%	3.47%
EPS (Basic)	2.17	2.07	1.64	1.31	0.86
EPS (Diluted)	2.13	2.03	1.62	1.29	0.84
EPS Growth	4.93%	25.31%	25.58%	53.57%	-
Free Cash Flow	215.66	185.66	110.86	69.26	119.29
Free Cash Flow Per Share	3.57	3.13	1.90	1.20	2.08
Gross Margin	48.70%	47.42%	46.44%	45.10%	45.16%
Operating Margin	12.79%	12.39%	10.74%	9.41%	7.85%
Profit Margin	8.48%	8.87%	7.51%	6.47%	4.51%
Free Cash Flow Margin	14.23%	13.69%	8.82%	6.02%	11.10%
EBITDA	317.07	270.75	225.05	190.07	168.46
EBITDA Margin	20.92%	19.96%	17.90%	16.51%	15.68%
D&A For EBITDA	123.17	102.71	89.99	81.8	84.07
EBIT	193.9	168.04	135.07	108.26	84.4
EBIT Margin	12.79%	12.39%	10.74%	9.41%	7.85%
Effective Tax Rate	24.83%	19.76%	15.77%	9.82%	10.13%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q